NASDAQ · INMB
INmune Bio, Inc.
Healthcare · Biotechnology
$1.33
Up+$0.01 (+0.76%)
Updated Nov 5, 2026, 3:24 AM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 56.63M
- P/E ratio
- -1.14
- Dividend yield
- 0.00%
- 52-week range
- $1.09 – $2.60
- Volume
- 258.64K
- Avg. volume
- 455.95K
Price performance · INMB
INMB price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
INMB closed at $1.33 after 21 trading sessions, down 28.49% for the selected period.
- Last close
- $1.33
- Period change
- -28.49%
- Period low
- $1.32
- Period high
- $1.89
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $1.35 | $1.40 | $1.28 | $1.33 | 258.64K |
| Nov 3, 2026 | $1.40 | $1.42 | $1.30 | $1.32 | 235.73K |
| Nov 2, 2026 | $1.47 | $1.49 | $1.365 | $1.38 | 203.57K |
| Oct 30, 2026 | $1.53 | $1.555 | $1.43 | $1.45 | 184.1K |
| Oct 29, 2026 | $1.53 | $1.65 | $1.53 | $1.60 | 185.89K |
| Oct 28, 2026 | $1.50 | $1.53 | $1.46 | $1.53 | 188.54K |
| Oct 27, 2026 | $1.41 | $1.53 | $1.40 | $1.52 | 274.78K |
| Oct 26, 2026 | $1.47 | $1.49 | $1.41 | $1.43 | 162.79K |
| Oct 23, 2026 | $1.53 | $1.53 | $1.45 | $1.46 | 190.56K |
| Oct 22, 2026 | $1.58 | $1.63 | $1.52 | $1.54 | 220.7K |
| Oct 21, 2026 | $1.61 | $1.69 | $1.60 | $1.61 | 229.97K |
| Oct 20, 2026 | $1.53 | $1.63 | $1.53 | $1.60 | 75.6K |
| Oct 19, 2026 | $1.58 | $1.58 | $1.5101 | $1.54 | 156.58K |
| Oct 16, 2026 | $1.68 | $1.68 | $1.56 | $1.57 | 196.17K |
| Oct 15, 2026 | $1.60 | $1.68 | $1.53 | $1.65 | 628.02K |
| Oct 14, 2026 | $1.70 | $1.915 | $1.59 | $1.60 | 1.14M |
| Oct 13, 2026 | $1.77 | $1.79 | $1.64 | $1.68 | 247.32K |
| Oct 12, 2026 | $1.89 | $1.89 | $1.78 | $1.78 | 72.74K |
| Oct 9, 2026 | $1.84 | $1.91 | $1.84 | $1.89 | 91.63K |
| Oct 8, 2026 | $1.85 | $1.87 | $1.79 | $1.83 | 379.17K |
| Oct 7, 2026 | $1.82 | $1.88 | $1.82 | $1.86 | 104.38K |
Latest INMB news
The latest Smart Investors Daily articles mentioning INMB.
Stock researchResearch & News · News
Company
Market Activity
Research & News

